Locked nucleic acid as a novel class of therapeutic agents

Locked Nucleic Acid (LNA) is a nucleic acid analogue with unprecedented binding affinity and excellent specificity toward complementary RNA and DNA oligonucleotides. The remarkable properties of LNA have led to applications within various gene silencing strategies both in vitro and in vivo. In the present review, we highlight the uses of LNA for regulation of gene expression with emphasis on RNA targeting.

[1]  Frank Baas,et al.  Evaluation of locked nucleic acid–modified small interfering RNA in vitro and in vivo , 2007, Molecular Cancer Therapeutics.

[2]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[3]  Peter E. Nielsen,et al.  LNA (Locked Nucleic Acids): Synthesis and High-Affinity Nucleic Acid Recognition. , 1998 .

[4]  V. Scaria,et al.  Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function. , 2009, Angewandte Chemie.

[5]  Poul Nielsen,et al.  LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition , 1998 .

[6]  J. Wengel.  Synthesis of 3‘-C- and 4‘-C-Branched Oligodeoxynucleotides and the Development of Locked Nucleic Acid (LNA) , 1999 .

[7]  J. Wengel,et al.  LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. , 2004, Biochemistry.

[8]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[9]  J. Wengel,et al.  Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology. , 2004, Oligonucleotides.

[10]  B. Gazzard,et al.  Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS. , 2002, American journal of ophthalmology.

[11]  S. Douthwaite,et al.  LNAzymes: incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. , 2002, Journal of the American Chemical Society.

[12]  S. Jayasena.  Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.

[13]  Michael Petersen,et al.  Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids. , 2002, Journal of the American Chemical Society.

[14]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[15]  C. Di Primo,et al.  LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1. , 2004, Nucleic Acids Research.

[16]  J. Wengel,et al.  Polymerase chain reaction and transcription using locked nucleic acid nucleotide triphosphates. , 2008, Journal of the American Chemical Society.

[17]  C. Di Primo,et al.  LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. , 2007, Blood cells, molecules & diseases.

[18]  T. Ishida,et al.  Synthesis of 2′-O,4′-C-Methyleneuridine and -cytidine. Novel Bicyclic Nucleosides Having a Fixed C3′-endo Sugar Puckering. , 2010 .

[19]  Thomas Tuschl,et al.  siRNAs: applications in functional genomics and potential as therapeutics , 2004, Nature Reviews Drug Discovery.

[20]  B. Berkhout,et al.  Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites , 2007, Retrovirology.

[21]  S. Kauppinen,et al.  Locked nucleic acid (LNA): High affinity targeting of RNA for diagnostics and therapeutics , 2005, Drug Discovery Today: Technologies.

[22]  C. Di Primo,et al.  Systematic screening of LNA/2′‐O‐methyl chimeric derivatives of a TAR RNA aptamer , 2007, FEBS letters.

[23]  Michael Famulok,et al.  Nucleic Acid Aptamers — From Selection in vitro to Applications in vivo , 2000 .

[24]  Volker A Erdmann,et al.  Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. , 2004, Nucleic acids research.

[25]  J. Wengel,et al.  Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development. , 2001, Current opinion in molecular therapeutics.

[26]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[27]  J. Wengel,et al.  NMR studies of fully modified locked nucleic acid (LNA) hybrids: solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid. , 2004, Bioconjugate chemistry.

[28]  S. Kauppinen,et al.  LNA-mediated microRNA silencing in non-human primates , 2008, Nature.

[29]  Michael Petersen,et al.  LNA: a versatile tool for therapeutics and genomics. , 2003, Trends in biotechnology.

[30]  Y. Hari,et al.  Stability and Structural Features of the Duplexes Containing Nucleoside Analogues with a Fixed N‐Type Conformation, 2′‐O,4′‐C‐Methyleneribonucleosides. , 1998 .

[31]  J. Wengel,et al.  LNA (Locked Nucleic Acid): An RNA Mimic Forming Exceedingly Stable LNA:LNA Duplexes , 1998 .

[32]  C. Di Primo,et al.  Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides. , 2006, Biochemistry.

[33]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[34]  G. Study.  Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS , 2002 .

[35]  J. Wengel,et al.  Efficient enzymatic synthesis of LNA-modified DNA duplexes using KOD DNA polymerase. , 2009, Organic & biomolecular chemistry.

[36]  J. Kjems,et al.  Improved silencing properties using small internally segmented interfering RNAs , 2007, Nucleic acids research.